News

Biggest stock movers Thursday: ABNB, DKNG, LLY, and more
Stock futures edged higher early Thursday as investors weighed President Donald Trump's newly announced 100% tariff on ...
Stocktwits on MSN1h
Dow Futures Rise As Trump’s Reciprocal Tariff Deadline Kicks In: AAPL, NVDA, INTC, LLY, SRPT Among Stocks To Watch
U.S. stocks appear set for a positive opening on Thursday as President Donald Trump’s deadline for reciprocal tariffs kicked in from midnight Thursday. In a post on Truth Social, President Trump ...
Eli Lilly (LLY) Partners with LTZ to Develop Myeloid Engager Therapies
Eli Lilly & Company (NYSE:LLY) is one of the top 10 medical AI companies to buy according to analysts. On July 29, the ...
Novo Nordisk plans cost cuts amid slower Wegovy growth outlook
Novo Nordisk (NVO) said Wednesday it will cut costs as it faces increasing competition from Eli Lilly (LLY) and generic ...
Eli Lilly Reverses Early Weakness, Closes Near Day's High After Key Trading Signal
A significant trading signal flashed for Eli Lilly (LLY) at a price of $755.87, after which LLY rose up to 1.8% and closed ...
Jim Cramer Shows Concerns That Eli Lilly “Might Be a Little Diluted”
Eli Lilly and Company (NYSE: LLY) is one of the stocks in Jim Cramer’s game plan for this week. Cramer highlighted that his ...
Zacks.com on MSN2d
Insights Into Lilly (LLY) Q2: Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Lilly (LLY) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of ...
Spotlight on Eli Lilly: Analyzing the Surge in Options Activity
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...